Solvay. Brigitte Laurent Senior Vice President Group Innovation Champion. SOLVAY S.A. Proprietary
|
|
- Godfrey Horace Harris
- 6 years ago
- Views:
Transcription
1 Solvay Brigitte Laurent Senior Vice President Group Innovation Champion May 18th, 2011
2 Outline Solvay Group Innovation highlights : Key initiatives Conclusions 2011, SOLVAY SA 2
3 About Us SOLVAY is an international industrial Group active in Chemistry. It offers a broad range of products and solutions that contribute to improving quality of life. Headquarters in Brussels About people in 50 countries on every continent with a growing presence in Asia, the Americas and Eastern Europe Diversified customer base 2010 Results Sales: EUR 7.1 Bn (in Eur) REBIT: EUR 602 m (in Eur) 2011, SOLVAY SA 3
4 SOLVAY: A rich history, A strong tradition 1861 Ernest Solvay discovered the key to the «industrial manufacture of soda ash using sea salt, ammoniac and carbonic acid» 1863 Creation of Solvay & Cie, a partnership Patented Solvay process for producing soda ash Founders: Ernest & Alfred Solvay, 2 brothers, age 25 and , SOLVAY SA 4
5 Plastics Strategic developments Innovation and geographic expansion Increase in the holdings in Vinythai (from 50% to 59%) Construction of new Vinyls production unit in Russia (2013) Recent capacity expansions in Specialty Polymers to support Asian growth Specialty polymers compounding plant in China (1H12) Capacity extension of TECNOFLON (1H12) R&D centers in India, South Korea and China Sustainable development and environmental footprint Successful launch of new PVDF for Lithium-ion batteries Electrolysis conversion membrane in Belgium (2012) Continued focus on competitiveness Closure of non competitive plants at Pipelife Untying of Vinyls JV with Arkema in Spain and France Industrial upgrade across the board 2011, SOLVAY SA 5
6 Chemicals Strategic developments Innovation and geographic expansion Construction of Epicerol plant in Thailand (2012)* Project to construct Epicerol plant in China (2013)* New HPPO plant with Dow Chemicals in Thailand (3Q11) Construction of H 2 O 2 plant in China with Huatai Group (2011) Electronic grade hydrogen fluoride production unit in China R&D centers in India, South Korea and China Sustainable development and environmental footprint Bicarbonate from unused soda ash by-products in USA Electrolysis conversion membrane in France (2012) Refuse Derived Fuel cogeneration plant in Germany Continued focus on competitiveness Restructuration of Fluor activities in Italy & Germany (*): Contributes also to sustainability 2011, SOLVAY SA 6
7 New Business Development Growth platforms Future Businesses Fuel Cells Solvicore- strong partnership with VW & Daimler Reinforced membranes Investment in ACAL (stationary market) as cost leader Demonstration projects in Lillo and Warrington Organic Printed Electronics Solvay s major investor within Plextronics backbone of our Organic Electronics & Organic Photovoltaic Strategy Investment in Polyera complementary to Plextronics in printed transistors Solvay Global Network (Universities, ) Advanced Technologies Nanotechnologies Example of supports : fluorinated fluids, micro lenses, microfluidic; blue pigments for LCD (Korea, in production), polymer additivation, Renewable Based Materials Bio-based polymers and monomers (lactide, furans) Exploration in ligno-cellulosis (wood, biomass) Venturing Conduit Ventures (2006 Hydrogen and Fuel Cells Technologies) Pangea Ventures (2008 Organic Printed Electronics & Organic Photovoltaic) Capricorn Cleantech Fund (2009 Greenchemistry) Korea Advanced Material Fund (2010 Organic Electronics & batteries) 2011, SOLVAY SA 7
8 Solvay Defines Innovation As New Business Innovation is the process by which an enterprise converts the creativity of its employees and partners into added value, faster and better than its competitors. Customer Oriented Projects Performance Improvement Management Improvement Sustainable Development & Citizenship Replicated Innovations 2011, SOLVAY SA 8
9 Driving Innovation «Mutli- faceted challenge requires Multi faceted solutions & initiatives» Strengthen the Group s innovation capabilities requires a structured approach of actions on the 4 critical enablers. Strategy & Leadership Strategic objectives alignment, Balance short vs. long term, Risk approach Leadership Create Create a strategy strategy to to explicity explicity embed embed innovation innovation People Values Talent management, Corporate entrepreneurship, Training & coaching, Boost the cultural & technical enablers Reward & recognition Resources & Partnerships Organisation, funding opportunities Partnership approach, Knowledge management IP) Design Design role role & structure structure to to support support innovation innovation Processes & Tools Market intelligence, Strategic Planning, IP Idea management, Portfolio management, Develop the appropriate technology & tools 2011, SOLVAY SA 9
10 Strategy & Leadership scorecard Innovation scorecard Performance Indicators Results (outputs) 1a 1b New sales ratio (%)- Products/ services New Sales ratio (%)- Technology Growth pipeline Competitiveness pipeline Partnerships People Involvement 1c New sales ratio (%)- Countries Expected value of New Business project pipeline (MEUR) Expected value of Competitiveness Improvement project pipeline (MEUR) % of innovation projects realized with external partners # of accepted innovation ideas per employee (on average) Management involvement (%) Target and/or benchmark R&D 7 8 Radical innovation spending (%) # of Patents issued/filed 2011, SOLVAY SA 10
11 People Solvay Innovation Trophy and Solvay Science for Innovation Year Total submissions Submitted to Jury (cap) Priorities 2009: Resilience and Sustainable Growth Record level of SIT 2009 participation Winners SIT 2009: New solef PVDF for lithium ion batteries Lightest airline catering trolley in Radel Palladium catalyst for H2O2 production S-300 expansion in Green River Selective catalytic NOx reduction for diesel engines High-tech world of organic electronics link to external collaborations with IMEC, Plextronics,... Year October 2010 SFI 2010: Science for Sustainable Development 2011, SOLVAY SA 11
12 People Communication Keeping Communication through all different support & Channels 2011, SOLVAY SA 12
13 Resources & Partnerships Innovation Network The primary goal of the Network is to embed innovation into their respective entity, in support of the management, by: > encouraging a pro-active innovative spirit > sharing innovative initiatives and objectives > catalyzing innovative initiatives and projects > monitoring progresses (processes follow-up, indicators,...) > networking: working closely with the Group Innovation Network. 2011, SOLVAY SA 13
14 Resources & Partnerships Open Innovation and Collaborations or Leveraging external and internal knowledge, and capability to accelerate a and enrich innovations through well selected across-boundary collaborations Process Some of our Collaborations What tools, metrics and management techniques use the business to implement collaborations? 4.Execution What external resources do the business need to succeed in its objectives? 1.Strategic goal Organic Flemish Institute Electronic Carbon Hydrates Vinyls Chinese Academy of Sciences Business Objective 3.Finding right collaboration 2.Scouting Organic Electronic UCL AFM & Innovation & H2O2 Organic Electronic Fluor Vinyls Organic Electronic Fluor What processes the business use to plan,structure and negotiate to set up or access partnerships? What mechanisms do the business use to find these resources? BIR&D Vinyls, Molecular Solutions 2011, SOLVAY SA 14
15 Resources & Partnerships Partnership in Solar Impulse A message of hope By uniting our efforts, we will be able, through technology, to open new avenues for solving the challenges facing humanity. An airplane able to take off autonomously and to fly day and night with a pilot on board. 2011, SOLVAY SA 15
16 Resources & Partnerships Partnership in Solar Impulse SOLVAY: contributing to innovative solutions Insulation Structure Metal Remplacement Lubricant [-60 C ~ +70 C] Batteries Efficiency Photovoltaïc cells (encapsulation) 2011, SOLVAY SA 16
17 Processes & Tools Innovation tools & measures InnoPlace electronic idea box E-pda individual innovation objective Innovation scorecard 2011, SOLVAY SA 17
18 Conclusions Critical Balance between Strategy, People and Systems Strengthening capabilities and organisational setup significantly enhance innovation process and 2011, SOLVAY SA 18
19 Thank you 2011, SOLVAY SA 19
Table of Contents. 1. About Solvay Solvay at a Glance Group Portfolio Transforming Solvay Solvay s Portfolio Upgrade 7
Solvay Media Kit Table of Contents 1. About Solvay 3 1.1. Solvay at a Glance 4 1.2. Group Portfolio 5 2. Transforming Solvay 6 2.1. Solvay s Portfolio Upgrade 7 3. Organizing for the Future 9 3.1. Why
More informationOpening New Frontiers
Opening New Frontiers Roadshow presentation 2Q11 results 1 2 AGENDA Solvay, an industrial group active in Chemistry Friendly offer on Rhodia 2Q11 results 3 SOLVAY GROUP SOLVAY at a glance SOLVAY AN INDUSTRIAL
More informationSpiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria
Spiros Nomikos Chief Executive Officer Solvay Sodi Bulgaria FINANCIAL TIMES INVESTING IN BULGARIA CONFERENCE Investment Opportunities in Bulgaria The Case of Solvay Sodi Spiros Nomikos CEO of Solvay Sodi
More informationHealth for Humanity 2020 Goals 2
2017 for Humanity Report Better for Humanity 2020 s 2 At Johnson & Johnson, we aspire to profoundly change the trajectory of health for humanity. Our for Humanity 2020 s, underpinned by 16 targets, focus
More informationSolvay expands its specialty polymers offerings with Ryton PPS acquisition
Solvay expands its specialty polymers offerings with Ryton PPS acquisition Sustained strategic portfolio realignment With Ryton PPS* acquisition, Solvay further strengthens unmatched leadership in Specialty
More informationAn exciting combination in a high growth, high margin Nutrition category. Name of chairman
An exciting combination in a high growth, high margin Nutrition category 2 Vevey, December 14, 2006 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationTeamFactory. How Solvay and Team Academy Created an In-Company Learning Environment That Learns by Itself
How Solvay and Team Academy Created an In-Company Learning Environment That Learns by EFMD Excellence in Practice Award 2008 -competition Norway, Oslo, June 2008 Etienne Collignon & Johannes Partanen &
More informationBuilding a new model of sustainable chemistry. Meeting with Investors at VFB-Happening 2014 Karim Hajjar CFO
Building a new model of sustainable chemistry Meeting with Investors at VFB-Happening 2014 Karim Hajjar CFO Solvay at a glance Acceleration of Solvay s transformation Delivery in a challenging economic
More informationSolvay India April 2017
Solvay India April 2017 Solvay in India Ahmedabad, Jodhpur, Bhiwani Hichem (JV) (GUAR) Solvay Specialty Polymer India & Panoli Solvay Engineering Plastics (PEEK, PAEK Polysulfones, Polyamide compounds)
More informationGlobal Zinc Chemicals Market Study ( )
Global Zinc Chemicals Market Study (2014 2025) Table of Contents 1. INTRODUCTION 1.1. Introduction to Zinc Chemicals Market Product Description Properties Industry Structure Value Chain Market Dynamics
More informationNordea investor meeting. June 18 th, 2018 Kristian Villumsen, EVP Chronic Care
Nordea investor meeting June 18 th, 2018 Kristian Villumsen, EVP Chronic Care Chronic Care represents more than 75% of Coloplast sales and we continue to outgrow the market FY 15/16 Chronic Care Rest of
More informationGlobal EHS Leaders Survey 2017: EHS Consulting Brands
Global EHS Leaders Survey 017: EHS Consulting Brands N O V E M B E R 0 1 7 W W W. V E R D A N T I X. C O M Global EHS Leaders Survey 017: EHS Consulting Brands This report helps strategy leaders, chief
More informationDriving Profitable Growth
Driving Profitable Growth through science-based, sustainable solutions Feike Sijbesma, CEO Royal DSM CONSUMER ANALYST GROUP EUROPE, London 22 March 2016 ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor
More informationLaunch of a new binders : Leveraging innovation to an economic advantage.
Launch of a new binders : Leveraging innovation to an economic advantage. Maximizing customers benefit by reducing cost of change Roberta Colombo & Thierry Baert The cost of innovation for materials. The
More informationPartnering for Growth
Partnering for Growth JP Morgan Healthcare Conference Simon Lowth, Chief Financial Officer, AstraZeneca 9 January 2013 Partnering for Growth Agenda Our platforms for growth Partnering strategy and capabilities
More informationGlobal Terephthalic Acid (PTA) Market Study ( )
Global Terephthalic Acid (PTA) Market Study (2014 2025) Table of Contents 1. INTRODUCTION 1.1. Introduction to Terephthalic Acid Market Product Description Properties Industry Structure Value Chain Market
More informationBuilding a model of sustainable chemistry
Building a model of sustainable chemistry March, 2015 Focused on bringing worldclass & sustainable Chemistry Solvay in India 264 million net sales ( Excl. JV but includes ~64 meuro export) 778 Employees
More informationCochlear Limited 2017 Annual General Meeting Chairman s Address
Cochlear Limited 2017 Annual General Meeting Chairman s Address 17 October 2017 Rick Holliday-Smith Chairman Ladies and gentlemen Financial results Cochlear reported a record net profit of $224 million,
More informationGlobal Polybutylene Terephthalate (PBT) Market Study ( )
Global Polybutylene Terephthalate (PBT) Market Study (2014 2025) Table of Contents 1. INTRODUCTION 1.1. Introduction to Polybutylene Terephthalate Market Product Description Properties Industry Structure
More informationVision. Mission. Hopelink s Values. Introduction. A community free of poverty
Vision A community free of poverty Mission Hopelink s mission is to promote self-sufficiency for all members of our community; we help people make lasting change. Hopelink s Values Growth and Human Potential
More informationADM to Acquire Neovia and Probiotics International Limited. July 2, 2018
ADM to Acquire Neovia and Probiotics International Limited July 2, 2018 Safe Harbor Statement 2 Some of our comments constitute forward-looking statements that reflect management s current views and estimates
More informationR&D Status in Romania
R&D Status in Romania Romania Economy is the second largest country in the Central and Eastern Europe (after Poland); it has a population of 22 million people; it benefits from a strategic geographic position;
More informationClusters in Sports Industry: EU Approach and Support
Enterprise and Industry José Freitas Policy Officer SMEs: Clusters and Emerging Industries unit Clusters in Sports Industry: EU Approach and Support EPSI Conference on Sports and Innovation June 13 th,
More informationHuman Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS
Human Nutrition Jeremy Xu President Human Nutritional & Health ROYAL DSM HEALTH NUTRITION MATERIALS Safe harbor statement This presentation may contain forward-looking statements with respect to DSM s
More informationChronic Care Coloplast Meet the Management London 2017 Kristian Villumsen, EVP Chronic Care Edmond Veome, SVP Chronic Care North America
Chronic Care Coloplast Meet the Management London 2017 Kristian Villumsen, EVP Chronic Care Edmond Veome, SVP Chronic Care North America Chronic Care represents more than 75% of Coloplast sales and we
More informationNestlé Investor Seminar 2008
Nestlé Investor Seminar 2008 Nestlé Nutrition update on Acquisitions Richard Laube CEO Nestlé Nutrition 1 Disclaimer This presentation contains forward looking statements which reflect Management s current
More information2015 Investor Conference
2015 Investor Conference ACCELERATING PROFITABLE GROWTH Jill Schaaf President, Renal Care Teeramanas Tanaekakarapong, ESRD Patient, Bangkok, Thailand Becoming The Global Leader In Renal Care Our Global
More information2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award
2018 Global Value-based Digital Dental Competitive Strategy Innovation and Leadership Award 2018 Contents Background and Company Performance Industry Challenges... 3 Strategy Innovation and Customer Impact...
More informationA GLOBAL LEADER IN PERSONALIZED NUTRITION
A GLOBAL LEADER IN PERSONALIZED NUTRITION Forward Looking Statements Management will make forward-looking statements during this presentation. Actual results could differ from those projected in such forward-looking
More informationCompany presentation. SEB Nordic Seminar Bella Sky, Copenhagen. Carsten Hellmann, President & CEO 9 January 2018
Company presentation SEB Nordic Seminar Bella Sky, Copenhagen Carsten Hellmann, President & CEO 9 January 2018 Allergy: a global disease with a large unmet need >500 million people affected by allergic
More informationGlobal EHS Leaders Survey 2018: EHS Consulting Brands
Global EHS Leaders Survey 2018: EHS Consulting Brands N O V E M B E R 2 0 1 8 W W W. V E R D A N T I X. C O M Global EHS Leaders Survey 2018: EHS Consulting Brands This report helps strategy leaders, chief
More informationFood & Beverages Food for a growing world
Food & Beverages Food for a growing world Rasmus von Gottberg, Vice President F&B Marketing, Novozymes Christel Thea Jørgensen, Vice President R&D, Novozymes Jeremy Bentham, Go to Market Director, Cargill
More informationCYCLOTRONS WORLD MARKET REPORT & DIRECTORY EDITION TOC and Summary USED IN NUCLEAR MEDICINE MARKET DATA, COMPANIES PROFILES.
CYCLOTRONS USED IN NUCLEAR MEDICINE WORLD MARKET REPORT & DIRECTORY MARKET DATA, COMPANIES PROFILES TOC and Summary EDITION 2015 A report written by Paul-Emmanuel Goethals & Richard Zimmermann Page 1/5
More informationInnovator Case Studies: Oncology Networks
Innovator Case Studies: Oncology Networks J. Ike Nicoll Chief Executive Officer Cancer Clinics of Excellence Alan Armer, Ph.D. Vice President, Research & Development Catholic Health Initiatives Cancer
More informationA world leader in allergy immunotherapy
A world leader in allergy immunotherapy Investor Relations presentation June 2017 1 I Investor Relations presentation I June 2017 ALK: Towards redefining treatment of severe allergies The commercial leader
More informationBALCHEM CORPORATION. Q Investor Relations Presentation
BALCHEM CORPORATION Q4 2017 Investor Relations Presentation Balchem Corporation Balchem develops, manufactures, and markets specialty ingredients that improve and enhance the health and well being of life
More informationJP Morgan 2011 Healthcare Conference. David Redfern, Chief Strategy Officer 12 January 2011
JP Morgan 2011 Healthcare Conference David Redfern, Chief Strategy Officer 12 January 2011 GSK performance through patent cliff + Avandia GSK patent cliff + Avandia 2006-2009 US turnover for se elected
More informationPPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM
HEMATOLOGY ONCOLOGY PPD S EXPERT HEMATOLOGY AND ONCOLOGY TEAM COMMITTED TO ADVANCING DRUG DEVELOPMENT IN ONCOLOGY $ MARKETPLACE COMPLEXITIES increasingly competitive marketplace and rising cost pressures
More informationPurolite Life Sciences Brand Positioning Catalyst
Purolite Life Sciences Brand Positioning Catalyst Presenting Brand Therapy Perceptions Goals Admired Brands Brand Narrative Brand Legacy Brand Story Vision, Mission, Promise Primary Messaging Brand Therapy
More informationEPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets
EPIDEMIOLOGY Accurate, in-depth information for understanding and assessing targeted markets WHY ACCURATE MARKET FORECASTS Start with accurate understanding Epidemiology is the study of disease patterns
More informationHarm de Wildt MD TNI
Harm de Wildt MD TNI Nutreco Capital Markets Day Derbyshire, UK 17 September 1 2013 Agenda 1 2 3 Market overview Animal Nutrition Europe Animal Nutrition strategic priorities Application Solution Centres
More informationA world leader in allergy immunotherapy. Jefferies Global Healthcare Conference, London : 19 November 2014 : Flemming Pedersen, CFO & EVP
A world leader in allergy immunotherapy ALK at a glance Leading allergy immunotherapy (AIT) specialist AIT: Treats the root cause of allergy Products in all areas of AIT ALK has 33% of the global AIT market
More informationAlpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic
Alpha-fetoprotein (AFP) Testing Market: By Cancer Type (Liver Cancer, Testes Cancer, Ovarian Cancer, Biliary Tract Cancer, Stomach Cancer, Pancreatic Cancer, Others (Cirrhosis, and Hepatitis)) & Geography-Forecast
More informationSTRATEGIC PLAN
2019-2022 STRATEGIC PLAN Thank you for your interest in our work! On behalf of The Friends staff and board of directors, we are excited to share our 2019-2022 Strategic Plan with you. This document represents
More informationGenomic Health. Kim Popovits, Chairman, CEO and President
Genomic Health Kim Popovits, Chairman, CEO and President Safe Harbor Statement Various remarks that we make in this presentation that are not historical, including those about our future financial and
More informationSTRATEGIC PLAN
STRATEGIC PLAN 2019-2028 3 EXECUTIVE SUMMARY Health at the center Good health changes everything. With good health, children can learn, parents can provide and neighbors can work together to build, and
More informationBoston Scientific is advancing...
Boston Scientific is advancing... Our mission Our values Boston Scientific is dedicated to transforming lives through innovative Caring Meaningful Innovation High Performance medical solutions that improve
More informationDelivering Results POSITIONED FOR GROWTH. Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental
Delivering Results POSITIONED FOR GROWTH Analyst & Investor Day October 14, 2015 Paul Guggenheim CEO, Patterson Dental PAUL GUGGENHEIM CEO, Patterson Dental Former owner and president, Guggenheim Brothers
More informationNeo Solar Power Corporation. June, 2017
Neo Solar Power Corporation June, 2017 NSP at A Glance Founded: December, 2005 Products: Cells, Modules and Systems 2016 Year-End Capacity: Cell: > 2.20 GW Module: > 670 MW System: > 700 MW approved pipeline
More informationMichel BAIJOT Vice President, WW Business Development & Strategic Alliances
Technology Transfer and Vaccines: The GSK Experience WHO Workshop on Technology Transfer for Local Manufacturing Capacity of Vaccines Geneva, November 30th, 2010 Michel BAIJOT Vice President, WW Business
More informationNeo Solar Power Corporation. October 27, 2017
Neo Solar Power Corporation October 27, 2017 NSP at A Glance Founded: August, 2005 Products: Cells, Modules and Systems 2016 Year-End Capacity Cell: > 2.20 GW Module: > 670 MW System: > 700 MW approved
More informationAsia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Procedures Outlook to 2020
Asia-Pacific Endoscopic Retrograde Cholangiopancreatography (ERCP) Reference Code: GDMECR0107PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 3
More informationToward a healthier 2020
Toward a healthier 2020 How citizenship and sustainability can help more people live healthier lives Photo Credit: Peace Corps We re creating a new vision of health. A vision that expands the ways we ve
More informationValue creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO
Value creation through profitable growth Handelsbanken Nordic Large Cap Seminar, Stockholm 2016 Anders Lonning-Skovgaard, CFO Coloplast has four business areas all with global sales presence Group revenue
More informationONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE
CATALYSTS DRIVING SUCCESSFUL DECISIONS IN LIFE SCIENCES ONCOLOGY: WHEN EXPERTISE, EXPERIENCE AND DATA MATTER. KANTAR HEALTH ONCOLOGY SOLUTIONS: FOCUSED I DEDICATED I HERITAGE AT KANTAR HEALTH, ONCOLOGY
More informationFully Employed MBA (MGMT FE)
Fully Employed MBA (MGMT FE) 1 Fully Employed MBA (MGMT FE) Courses MGMT FE 200. Responding to Dynamic Times: Thinking Strategically in Organizations. 6 Units. Focuses on the strategic and organizational
More informationOur future workforce. Flemming Dahl, Senior Vice President and Head of Quality, Novo Nordisk
Our future workforce Flemming Dahl, Senior Vice President and Head of Quality, Novo Nordisk ISPE Nordic 17. Nov. 2016 2 Who am I? Head of Quality in Novo Nordisk 48 years Danish Married 5 Children [7-19]
More informationStraumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America
Media release Straumann s net revenues reach CHF 185 million in Q1, driven by continuing double-digit growth in America Group net revenue rises 2% (l.c.) as double-digit increases across America offset
More informationDeveloping & Commercializing Targeted Small Molecule Drugs in Cancer
Developing & Commercializing Targeted Small Molecule Drugs in Cancer SAFE HARBOR STATEMENT 2 Forward-looking statements made in the course of this presentation are made pursuant to the safe harbor provisions
More informationWhole Grain and High Fiber - Global Market Outlook ( )
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Whole Grain and High Fiber - Global Market Outlook (2015-2022) Whole Grain and High Fiber - Global Market Outlook
More informationTranscatheter Aortic Valve Replacement. Larry L. Wood Corporate Vice President
Transcatheter Aortic Valve Replacement Larry L. Wood Corporate Vice President Leader in ~$3.5B Global Transcatheter Aortic Valve Replacement Market Primary global growth drivers: indication expansion,
More informationElekta Innovation and Growth. ESTRO 2012 Capital Markets Presentation
Elekta Innovation and Growth ESTRO 2012 Capital Markets Presentation 15.00 Introduction Partner in cancer care Growth Tomas Puusepp President and CEO 15.30 Patient-focused development Cancer care solutions
More informationGBU data & processes
GBU data & processes Consumer Chemicals Novecare at a Glance Growth on inspired products Net sales 2013e 1.6 bn 11 prod. Sites (+1 under construction) 12 R&I centers 5 prod. Sites (+1 under construction)
More informationLetter to Shareholders SEMI-ANNUAL REPORT 2008
Letter to Shareholders SEMI-ANNUAL REPORT 2008 Dear Shareholder You have in your hand the first shareholder letter issued by Nobel Biocare. Thanks to the conversion of Nobel Biocare s bearer shares into
More informationFAMILY & CHILDREN S SERVICES STRATEGIC PLAN
2014-2019 FAMILY & CHILDREN S SERVICES STRATEGIC PLAN WHO WE ARE Family & Children s Services is a leading provider of behavioral health care and family services for people of all ages in Tulsa and surrounding
More informationThe Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration
The Trilateral FTA: A Pillar of Trilateral Cooperation and East Asia Economic Integration 2012.10.23 (TUE) North-East Asia Forum on Trade and Transport Facilitation 1 CONTENTS 1. Significance of Trilateral
More informationNestlé Dairy s new frontier: healthy ageing
Nestlé Dairy s new frontier: healthy ageing Thierry Philardeau Head of Dairy SBU Disclaimer This presentation contains forward looking statements which reflect Management s current views and estimates.
More informationMiFOOD2017. Grand Rapids April 18 th Daragh Maccabee SVP Procurement & Dairy Economics Glanbia Nutritionals
MiFOOD2017 Grand Rapids April 18 th 2017 Daragh Maccabee SVP Procurement & Dairy Economics Glanbia Nutritionals OUR BUSINESSES TODAY MARKET CAP 5BN EMPLOYEES 6,200 GLANBIA PERFORMANCE NUTRITION GLANBIA
More informationPartnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives. Oncology Therapeutic Area Janssen Research & Development, LLC
Partnering in Oncology Sharing a Vision to Help Prolong and Improve Patients Lives Oncology Therapeutic Area Janssen Research & Development, LLC The patients are waiting. Dr. Paul Janssen To Our Potential
More informationCanadian Mental Health Association Nova Scotia Division. Strategic Plan (last updated: June 28, 2016 TW; July 4, 2016 PM)
Canadian Mental Health Association Nova Scotia Division Strategic Plan 2015-2018 (last updated: June 28, 2016 TW; July 4, 2016 PM) VISION OF CMHA (NATIONAL) Mentally healthy people in a healthy society.
More informationThe value of integrated reporting
The value of integrated reporting Jesper Lindhardt Director Triple Bottom Line Strategy & Performance Management Novo Nordisk at a glance Key facts A focused pharmaceutical company with leading positions
More informationThe acquisition of Fortitech
The acquisition of Fortitech Accelerating DSM s strategy to become a full solutions provider in food ingredient blends Investor Relations 8 November 2012 Overview Fortitech at a glance Acquisition rationale
More informationAsia-Pacific Bariatric Surgery Devices Market Outlook to 2020
Asia-Pacific Bariatric Surgery Devices Market Outlook to 2020 Reference Code: GDMECR0195DB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2 List
More informationExpanding the boundaries of nutrition Luis Cantarell
Expanding the boundaries of nutrition Luis Cantarell Nestlé Investor Seminar 30 September 2013 Disclaimer This presentation contains forward looking statements which reflect Management s current views
More informationGlobal Cosmetic Dentistry Market Research Report 2018
Report Information More information from: https://www.wiseguyreports.com/reports/3029111-global-cosmetic-dentistry-market-research-report- 2018 Global Cosmetic Dentistry Market Research Report 2018 Report
More informationBRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook to 2020
BRIC Transurethral Resection of the Prostate (TURP) Procedures Outlook Reference Code: GDMECR0130PDB Publication Date: July 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables...
More informationWelcome to Galenicum! APRIL, 2013
Welcome to Galenicum! APRIL, 2013 Our corporate image comes from the sunrise. Night represents disease, daylight means health and the sunrise stands for overcoming GALENICUM CORPORATE PRESENTATION 3 Who
More informationPassion for progress, care for people
Passion for progress, care for people SPIL Analyst Meeting 25 th April, 2008 DISCLAIMER ACTUAL RESULTS / OUTCOMES MAY BE DIFFERENT FROM ANY FORWARD LOOKING STATEMENTS / VIEWS / ESTIMATES EXPRESSED HEREIN.
More informationCPH Chemie + Papier Holding AG. Investor Day. Perlen, 13 th September 2018
CPH Chemie + Papier Holding AG Investor Day Perlen, 13 th September 2018 Agenda 2.00 pm Welcome 2.05 pm Presentation Course of Business 2018 2.50 pm Break 3.00 pm Presentation Perlen Packaging 3.30 pm
More informationREFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC294DFR PUBLICATION DATE NOVEMBER 2013 PROTOPIC (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Protopic in the nine major pharmaceutical markets
More informationTransforming health through IT
@himsseurope HIMSS Europe 02 HIMSS Europe www.himss.eu The Leading Health IT Knowledge Organisation HIMSS Europe is a voice, advisor and thought leader of transformation through health IT. As an independent
More informationGELATIN & AKIOLIS. Because every bio-molecule counts. Pol Deturck EVP Chemicals & Organic Specialties
GELATIN & AKIOLIS Because every bio-molecule counts Pol Deturck EVP Chemicals & Organic Specialties Why our bioplatform is promising Dual service provider and highly reliable partner Akiolis, the 3 rd
More informationNEWSCLIPPINGS. Publication: Cincinnati Business Section: News
Publication: Cincinnati Business Section: News Journal Date: 11 Oct 2012 Page: Online Emery Oleochemicals planning $50M expansion in Cincinnati Summary : Emery Oleochemicals is investing $50 million to
More informationPutting ALK on the right growth trajectory
Putting ALK on the right growth trajectory Økonomisk Ugebrevs Kapitalmarkedseftermiddag 15. marts 2018 Per Plotnikof, VP Corporate Communications and IR Marts 2018 Allergy: a global disease with a large
More informationDuPont Nutrition & Health Craig Binetti, President
Craig Binetti, President Regulation G The attached charts include company information that does not conform to generally accepted accounting principles (GAAP). Management believes that an analysis of this
More informationWhat will women s empowerment mean for men? Selected facts and figures to spark your thinking
What will women s empowerment mean for men? Selected facts and figures to spark your thinking Prepared for the Women s Forum for the Economy and Society by PwC October 211 What will women s empowerment
More informationInnovation from the Foundation Sonya Dumanis, PhD
Highlights in Research and Innovation from the Foundation Sonya Dumanis, PhD Senior Director of Innovation EPILEPSY FOUNDATION Our Mission: To lead the fight to overcome the challenges of living with epilepsy
More informationMore information at
Report Information More information at https://www.htfmarketreport.com/reports/1288313 Global Homeopathic Products Market Professional Survey Report 2018 Report Code: HTF1288313 Pages: 111 Price: 1-User
More informationDentivera Milling Discs. Powering the Digital Revolution. Supported by Solvay. Make METAL-FREE Possible with Ultaire AKP. Dental Lab Advantages
Powering the Digital Revolution Dental Lab Advantages Increasingly, labs are moving toward digital dentistry. Ultaire AKP is custom-formulated to take full advantage of the digital workflow so you can
More informationREFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) FORECAST AND MARKET ANALYSIS TO 2022
REFERENCE CODE GDHC295DFR PUBLICATION DATE NOVEMBER 2013 ELIDEL (ATOPIC DERMATITIS) Executive Summary The below mentioned table presents key metrics for Elidel in the major pharmaceutical markets: the
More informationThe Prime Minister s Challenge on Dementia & 2013, G8 Dementia Legacy Making it Happen
The Prime Minister s Challenge on Dementia & 2013, G8 Dementia Legacy Making it Happen 1 Gill Ayling Head of Department of Health, UK The Key Challenges The Dementia Journey 1. The Prime Minister s Challenge
More informationDiabetic Retinopathy Treatment - Global Market Outlook ( )
Published on Market Research Reports Inc. (https://www.marketresearchreports.com) Home > Diabetic Retinopathy Treatment - Global Market Outlook (2015-2022) Diabetic Retinopathy Treatment - Global Market
More informationBayer s Commitment in Ophthalmology. Zig Lang, MD, PhD Vice President and Head of Medical Affairs & Pharmacovigilance, Bayer HealthCare Company Ltd.
Bayer s Commitment in Ophthalmology Zig Lang, MD, PhD Vice President and Head of Medical Affairs & Pharmacovigilance, Bayer HealthCare Company Ltd. Bayer s commitment to addressing unmet needs in ophthalmology
More informationChronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA
Chronic Care North America update Coloplast Capital Markets Day 2018 Manu Varma, Senior Vice President, Chronic Care Management, NA US Chronic Care has outperformed the market by a factor 2-3x and continues
More informationStrategy at Work. MedStar Health. Engaging people, improving performance
Strategy at Work MedStar Health Engaging people, improving performance About MedStar Health A $3.1 billion nonprofit health care organization formed in 1998 Headquartered in Columbia, MD Operates eight
More informationChief Development Officer National Brain Tumor Society
Send Nominations or Cover Letter and Resume to: Lisa Vuona Vice President 617-262-1102 lvuona@lllsearches.com Chief Development Officer National Brain Tumor Society Newton, MA http://braintumor.org/ The
More informationStrategic Directions
Strategic Directions 2015-2019 Peter MacCallum Cancer Centre Strategic Directions 2015-2019 THE BEST IN CANCER CARE We are a cancer centre unsurpassed in the world, where humanity, caring service and relentless
More informationTeam Acceleration Guide
Degrees of Strength Team Acceleration Guide www.degreesofstrength.com 2012 Verus Global Inc. All Rights Reserved. 1 Use this guide to develop and accelerate... (Guide pages 3-8) (Guide pages 8-9) (Guide
More informationChina Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020
China Cranio Maxillofacial Fixation (CMF) Market Outlook to 2020 Reference Code: GDMECC0079DB Publication Date: March 2014 Page 1 1 Table of Contents 1 Table of Contents... 2 1.1 List of Tables... 4 1.2
More information